Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Finland
Sweden
Denmark
Norway
Latest
Trending
Followed

Apotea, Webcast, Q1'26

By Inderes4/29/2026, 7:30 AM
Apotea

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Sarah Ahnström
00:02 - 00:29

Good morning, everyone, and welcome to Apotea first quarter report. Today, we will present from our office in Stockholm. And as usual, we will start with the presentation and then move on to a Q&A with spoken questions. And today's presenters will be Pär Svärdson, our CEO and co-founder, Johan Mårild, our CFO, and myself. Sarah Ahnström, COO. So let's begin.

Pär Svärdson
00:29 - 00:36

Thank you. We have had a good quarter with good profitability and stable growth.

Johan Mårild
00:37 - 00:53

Yes, we had revenues of 1,937,000,000 and a growth of 10.5% in the quarter and an operating margin in line with last year. The operating margin was 5.2%.

Pär Svärdson
00:56 - 01:08

And, as I said, we have had improved profitability and. We are experiencing stable growth, and our projects are progressing. I think they are heading in the right direction.

Sarah Ahnström
01:10 - 02:13

And since this fall, we have put a lot of focus into our growth initiatives. As we have said before, and some of these have now been launched. We're very happy about that. Most recently, we soft launched our site in Norway. Apotea.no, which means that we are now selling our health and beauty products on the Norwegian market under the Apotea brand on the site. And we are delivering the customer orders from our fulfillment center in Varberg. And this is, of course, a step to strengthening our position in Norway, as well as increasing the utilization of the new fulfillment center. And we have also continued during the quarter to scale up the production in Varberg. And we have sent out as much as 27,000 orders in one day. And we have done that by increasing the number of shifts, as we are now working both evening and weekend shifts. Approximately one-third of all customer orders are now going from Varberg.

Pär Svärdson
02:13 - 02:22

And when we launched this soft launch of Norway, we also launched our new platform. And that was a big step as well.

Johan Mårild
02:25 - 06:59

And with the growth in the quarter of 10.5%, we now have rolling 12-month revenues approaching 7.4 billion. And we have a rolling adjusted EBIT margin, which is flat compared to Q4 24. And it was 4.2%. And let's take a closer look on the revenues to the left. You see our net revenue development. And as mentioned, we had growth in the quarter of 10.5%, and the growth was not fairly evenly distributed across our product areas. Roughly 10% growth in Rx as well as in non-Rx. And we experience a continued solid demand for pharmaceutical products. Online, to the right. You see our gross margin, uh, we had a slight increase in the gross margin in Q1 compared to Q1 25. And the increase was the result of successfully executed campaigns as well as improved purchasing. Our ambition is to have a fairly stable gross margin and with attractive prices, attract more and more people to buy pharmacy products online. We had a strong operating profit in the quarter. We had an operating profit of 101 million. And the operating profit increased despite increased depreciations related to the new fulfillment center in Varberg, and the increase in operating profit was driven by increased net revenues as well as slightly higher gross margin, as mentioned, and continued good cost control. Let's talk more about the cost; then, to the right, you see a breakdown of our operating costs. And as you can see, the depreciations as a percentage of revenues increased in Q1 as expected. And the increase was related to the new fulfillment center in Varberg that was opened last year, and depreciation started in Q4 last year. If we then look on personnel costs and other operating costs and take those combined, these are fairly flat compared to a year ago. And we maintain good cost control, and as we've mentioned before, and worth mentioning again, the mix between personnel costs and other operating costs is also impacted by the usage of external staffing in our fulfillment centers. We did not have any items affecting comparability in Q1. We had a strong operating cash flow in Q1, and that was fairly stable compared to a year ago. We had limited investments in Q1. The investments in Q1 2025 were related to the new fulfillment center in Varberg, which is now the platform. Investments are completed, and we expect this year to have significantly lower CapEx level compared to a year ago. If we take a close look on the net working capital to the right, you can see that the inventory increased compared to a year ago, and the increase in inventory also impacted the inventory turnover rate somewhat, which is slightly lower, and the increase was noted. The increase in inventory was primarily the result of increased inventory in Varberg. We have slightly lower return on capital employed in Q1 compared to a year ago. However, it remains a strong, strong return and the decrease in return on capital employed is the result of the new assets related to the new fulfillment center in Varberg. And then finally, in terms of numbers, let's look at the net debt and the net cash position. At the end of March, we had a net cash position of 105 million Swedish Kronor. The increase in cash compared to a year ago was the result of strong underlying operating cash flow, as well as limited investments in Q1 2026.

Pär Svärdson
07:01 - 07:37

Our focus ahead is to continue to build the pharmacy of tomorrow, to improve the customer journey, and to improve our efficiency. And I think we have hundreds of projects to improve the customer journey, to make it a little bit easier for the customer, because retail is all about the customer. And if we can improve customer satisfaction, then we will both be more profitable and grow faster, and so on. So that's our primary focus.

Sarah Ahnström
07:38 - 08:55

Yes. And we will continue to have a very strong focus on growth going forward. And as we mentioned at the beginning, we have done a soft launch of the Apotea.no site, but that also means that we will continue to work on that site and continue to improve the customer offering in Norway, and we will also continue to evaluate and launch several growth-related initiatives going forward. Still, one of the examples of optimizing operations, also in terms of sales-oriented initiatives that we have undertaken, is that we have expanded our offering of refrigerated deliveries for pharmaceuticals in Sweden. And these types of initiatives with great potential, I would say, and we will, of course, also continue to scale up the production in Varberg. And the automation has a capacity of 50,000 orders each day. And as I mentioned in the beginning, we have reached 27,000 as of now. And so we will continue to optimize the operations, making sure that the system is stable even in higher volumes, and also work with related processes such as purchasing inventory levels and freight options from the facility. So I think we have not reached the maximum level yet.

Pär Svärdson
08:56 - 09:34

And as all of you already know, there is a lot of uncertainty out there in the world. And we haven't been affected yet. We haven't seen any signs of that. But we have a big focus on it every day because it can affect us in the future, but hopefully not. I mean, like logistics, where containers are in the world, and plastic bottles, and so on, but we haven't seen it, and we are in a very stable industry, but we have a focus on it. Thank you.

Sarah Ahnström
09:34 - 09:40

And that was the end of the presentation as well. So now we move on to the Q&A with spoken questions.

Operator
09:44 - 09:47

The next question comes from Johan Fredrik. Fred from Seb. Please go ahead.

Johan Frederik
09:49 - 10:04

Yes, good morning, guys. Johan Frederik from Seb. A few questions from my side, starting with the revenue growth. Could you give us a sense of the split between volume growth and sort of price mix effect in the quarter?

Johan Mårild
10:08 - 10:17

I think we have a fairly stable AOV in the period. Yeah.

Pär Svärdson
10:17 - 10:36

And I think we have some price effects, but it's more like a very expensive medicine. It's not like higher prices on the same product, but we sell more and more of very expensive medicines.

Johan Frederik
10:38 - 10:50

Okay. So, mix then was an important factor in our sales growth while sort of volume drove OTC growth. Is that correct?

Pär Svärdson
10:50 - 10:52

It's a little bit 50/50, isn't it?

Johan Mårild
10:52 - 11:17

I don't have the exact split, but yes, in terms of Rx, we had a positive impact from increased orders and/or an increased share from very expensive medicines. Whereas the volume was the main driver in the other segments.

Johan Frederik
11:19 - 11:39

Cool. Got it, got it. And on the gross margin came in at, I believe, 28.3%, which is, I believe, the highest gross margin you ever reported. How much of this was driven by sort of one-off campaign timing in the quarter and how much was structural improvements in procurement?

Pär Svärdson
11:40 - 12:31

If you compare with Q4, we have done a lot of improvements in how we buy things to our warehouses. And our goal is to have a stable gross margin; it goes a little bit up and a little bit down, but quite stable. And particularly in Q1, we have had successful campaigns. You should buy the products from the right source at the right time and the right amount to the right warehouse, do campaigns together with the supplier, and have successful campaigns. So it's, um, I mean, we have done a quite good job with that and we can absolutely try to do it next quarter as well. But it goes a little bit up and goes down.

Johan Frederik
12:33 - 12:44

Okay. So, more of a, I don't want to call it a one-off effect, but specifically relating to Q1, essentially the opposite of what happened in Q4. Is that correct?

Pär Svärdson
12:44 - 12:46

Yes, something like that.

Johan Frederik
12:48 - 13:09

And, in the light of this, how should we think about the revenue contribution from services? It grew 30% in Q1, I believe, is that relating to the campaigns you are alluding to, or is there anything that could indicate that this is a higher structural base going forward?

Pär Svärdson
13:11 - 13:18

And then we try to improve or raise that as well. But it's absolutely related to campaigns.

Johan Frederik
13:21 - 13:43

Okay. Got it. Got it. Makes sense. A final one then if I may, on Capex, which was minuscule here in Q1, you've previously guided for around 50 to 70 million, I believe, annually going forward. Does this still hold? And if so, what types of investments should we expect in 2026 to get to that number?

Pär Svärdson
13:45 - 14:22

We evaluate all possible investments we can do. And if we see that it's a profitable investment, we will do it. And this 50 to 70 is more like some kind of target. But we haven't found that much investment yet because we are now improving the investments we already have done. So, I think we will have to come back over time and elaborate on that.

Sarah Ahnström
14:23 - 14:40

I think if you look into the CapEx, we have done it step by step. So we have improved the efficiency by smaller investments. That has happened several times each year. And I think in our case, we still need to optimize the operations and so on.

Pär Svärdson
14:40 - 14:46

We have bought a few bins to Varberg. So we can store more stock.

Johan Frederik
14:48 - 15:14

Yeah. But I see your point, and the 50 to 70 million is quite a challenge, given that you essentially had no CapEx in Q1, it's quite a steep step up in the coming quarters then. But as I interpreted it from your answers, you have no sort of planned CapEx investments involved, but rather continue to optimize existing infrastructure.

Pär Svärdson
15:15 - 15:16

Not yet, but it might come.

Johan Frederik
15:19 - 15:21

Fair enough. Thank you so much for taking my questions.

Pär Svärdson
15:21 - 15:22

Thank you.

Operator
15:28 - 15:33

The next question comes from Benjamin Wahlstedt from ABG Sundal Collier. Please go ahead.

Benjamin Wahlstedt
15:35 - 16:16

Good morning, guys. I'm sorry to say I will go back to one of your questions. About the gross margin. I got the impression last conference call that while the campaign intensity was one issue you faced in Q4. The gross margin pressure you experienced was also an effect of purchasing to Varberg. I believe Johan said that you were still in the process of calibrating the purchases for the new logistics center. For example, in Q1, it appears Varberg purchasing is basically not an issue at all. Was this a quicker turnaround than you expected, or how should we think about this?

Pär Svärdson
16:17 - 16:47

We have absolutely done much better purchasing in the first quarter compared to the fourth. I don't think it's probably too early to say that all problems are gone and to be sure about that, because if you have just one quarter, it's a little bit too early. But I mean, we have absolutely improved our purchasing process and we will continue to improve it over time.

Benjamin Wahlstedt
16:50 - 17:05

Perfect. Thank you. Have you also written the CEO letter about planning more investments to ramp up growth? Could you elaborate on the kind of investments you are referring to here? Or is this Apotea.no website, for example?

Pär Svärdson
17:06 - 17:52

Sorry. I mentioned that we have built a new e-commerce platform. It's not an investment on the balance sheet, but it's working hours for the AI team and for the tech team. To improve the assortment, maybe do more in marketing. So it can be a lot of different areas, maybe not at big costs, but costs related to that. And we want to focus on growth and want to spend both money and time on building more growth. Because I think it's very valuable for both Apotea and for our shareholders.

Benjamin Wahlstedt
17:55 - 18:22

Perfect. Thank you. That's clear. And sort of following on that, then you mentioned marketing spend or marketing investments as an example of such investments. While you don't share marketing ratios explicitly, could you give us a hint or an indication of whether or not your marketing ratio is sort of up or down compared to the time of the IPO, for example?

Pär Svärdson
18:23 - 18:24

I think it is.

Johan Mårild
18:25 - 18:25

Stable.

Pär Svärdson
18:25 - 18:55

Quite stable. Our goal is to find profitable marketing and do that marketing. And for example, Google, it's not profitable to us to buy such terms. That is not profitable, but we want to buy as much as we can that is profitable.

Johan Mårild
18:55 - 19:44

And so that's something that we continuously evaluate the marketing spend. If we see that there is room to increase marketing in external channels with a good return on investment. That's something we do obviously. But, I think as we've shared before, the main driver for Apotea's growth has always been having the best offering to the consumer, ensuring that our attractive prices, speedy and free deliveries, and attractive and large assortment drive new customers and also keep them returning more frequently. So that's our main focus, ensuring that the deliveries and assortments are right, etc. .

Pär Svärdson
19:44 - 19:47

I hope the customer is a good customer. Yeah.

Johan Mårild
19:47 - 20:06

And it might seem like, and I think that's a good way to kind of drive growth. That's a long term sustainable way of driving growth rather than having short term adjustments in marketing. Big calibration in marketing or prices, for example.

Benjamin Wahlstedt
20:10 - 20:50

Thank you. That's very clear as well. Final one for me then. In essence, why do you not raise your short-term financial targets for the margin? You've shown in Q1 that you can deliver above 5% margins with the new setup running far from sort of max or optimum capacity. I guess one could assume that with further growth, you would scale more on the now higher D&A from Varberg, for example, for a rather positive margin trajectory from here, assuming continued growth. So. You are above the 3 to 5% interval. Why keep it intact?

Pär Svärdson
20:51 - 21:26

We mentioned just before the uncertainty in the world, and we want to grow faster and spend money on that. And I think we need a few more quarters. So, fourth quarter was not that good. So we need more time before we can say, okay, this is the new stable level where we can be, because we don't want to overpromise. So that's why we try to keep it that way.

Johan Mårild
21:26 - 22:04

And we are in the middle of this short-term to mid-term corridor of being within 3 to 5%. We have an adjusted EBIT margin rolling 12 months of 4.2%. So we are in the middle of that corridor. And even though Q4 was a disappointment, which we are fairly open about, its low profitability was below our expectations. Q4 tends to be, with the seasonal variation and higher share of campaign sales, a softer profit-wise quarter compared to the other three quarters during the year.

Benjamin Wahlstedt
22:08 - 22:10

Perfect. Thank you. That's all I have for now.

Unknown 1
22:11 - 22:11

Thank you.

Operator
22:13 - 22:18

The next question comes from Victor Hanson from NB Carnegie. Please go ahead.

Victor Hanson
22:20 - 22:43

Good morning Sarah. A couple of questions from my side. I was curious on your impressions of the competitive environment during Q1, because we've had some peers commenting on this recently. And it seems that the market remains tough, relatively low growth still. So what's your view on the competitive environment here.

Pär Svärdson
22:45 - 22:55

I think the competitive environment is quite stable as well. We have had a very competitive market for several years. And that's how we like it.

Victor Hanson
22:59 - 23:03

Okay. Perfect. So, no change?

Pär Svärdson
23:03 - 23:04

Change. No, not really.

Victor Hanson
23:04 - 23:27

Okay. Okay. My next question is on your beauty segment. Beauty products are up a lot. So, do you have any comments on how growth was within this segment and how important you would say beauty is for you going forward to reach your sales targets?

Johan Mårild
23:29 - 23:50

It's an important segment. It is a broad segment as well, right? So it contains a lot of different types of products and it's going well, good growth in that area. So it's one of the focus areas that we have. But I think in order to have a higher growth rate, we need to work on all categories.

Pär Svärdson
23:51 - 24:16

And we also have seasonal effects. Now we're heading towards the summer, and then you have seasonal products. That's a lot. In the autumn, you have different products. So all categories are very important for us, and we want to grow all of them. And we try to maximize the growth on all of them. So we try to handle them individually and try to do as well as we can with each one.

Sarah Ahnström
24:17 - 24:33

I think, specifically in the beauty segment, we have taken quite significant steps in terms of the assortment. So we're very proud to welcome a lot of good brands to our site, and that's something we have been very proud of, I would say. So we're happy to do so.

Pär Svärdson
24:33 - 24:34

We have much more now.

Sarah Ahnström
24:35 - 24:44

But I think we're very happy to see that the assortment is widening within those types of categories, and especially in the more premium segment, I would say.

Victor Hanson
24:46 - 25:04

Perfect. And then on Varberg here, I was hoping that you could perhaps provide an estimate of the savings effects, as you have lower fulfillment costs in Varberg compared to Nova. And now you said you moved one third of your total orders.

Johan Mårild
25:06 - 25:50

Yes. I think it's still early days. I mean, and I think we mentioned this before. Yes, we see significantly improved efficiency in Varberg. However, it's early days in terms of ramping up and understanding the more steady-state production costs in Varberg. And at the same time, we also are shifting the production between our sites and between different shifts. So it's at this point hard to say a fixed number, but we just see efficiencies in Varberg, and we will come back to that. Absolutely.

Victor Hanson
25:53 - 26:06

Okay. Perfect. And then a final question from my side. The consumer sentiment. It's tough now with another war going on. How did April start?

Johan Mårild
26:08 - 26:20

We will need to come back to Q2 in the summer when we report the Q2 results. Yes, I think so.

Pär Svärdson
26:21 - 26:22

Probably a good idea.

Victor Hanson
26:22 - 26:23

Fair enough.

Pär Svärdson
26:24 - 26:24

Thank you.

Victor Hanson
26:24 - 26:25

Thank you very much.

Unknown 1
26:29 - 26:29

Perfect.

Sarah Ahnström
26:29 - 26:37

Thank you everyone. That was the last question. Thank you for listening in to the presentation of our quarterly report. And we wish you a pleasant day.

Pär Svärdson
26:38 - 26:39

Thank you very much.

Johan Mårild
26:39 - 26:39

Bye.

Continue to the webcast
Revenio Group Oyj, Q3'26
Language: English11/12/2026, 1:00 PM
Jukka Kainulainen Good afternoon, and welcome to the Revenio Group Corporation Q3 Earnings Call. My name is Jouni Toijala. I am the CEO. And then, again today we have Jukka Kainulainen, our CFO, on th…
Kamux, Q3'26
Language: English11/12/2026, 9:00 AM
Katerina Heterant Good morning. Welcome to the Kamux Q3 results presentation. My name is Katerina Heterant and I am Head of Investor Relations at Kamux. Today we shall go through the Q3 results presen…
Koskisen, Webcast, Q3'26
Language: Finnish11/12/2026, 8:00 AM
Jukka Pahta Hyvää huomenta ja tervetuloa tähän osavuosikatsaustilaisuuteen! Koskisen tammi–syyskuun osavuosikatsaustilaisuuteen lähdetään otsikolla: Koskisen liikevaihdon kasvu jatkui. Kohonneet kusta…
Reaktor, Q3'26
Language: Finnish11/11/2026, 9:00 AM
Pekka Horo Oikein hyvää aamupäivää kaikille ja tervetuloa tähän meidän webcastiimme. Olen Pekka Horo, Reaktorin toimitusjohtaja, ja kanssani täällä on tänään Antti Akkanen, joka aloitti lokakuussa Rea…
Savox, Q3'26
Language: English11/10/2026, 11:00 AM
Paulina Tanila Our speakers today are CEO Jerry Kettunen and CFO Juha Järvi. Jerry will give an overview of Savox as a company and go through the highlights of the quarter. After that, Juha will conti…
Raisio Oyj, Webcast, Q3'26
Language: Finnish11/10/2026, 10:00 AM
Elli Siltala Hyvää marraskuista päivää Raisiosta! Ja tervetuloa Raision tammi-syyskuun 2026 osavuosikatsauksen webcastiin! Pahoittelut pienistä teknisistä haasteista, mitä meillä oli tässä alussa. Min…
Mandatum Oyj, Audiocast, Q3'26
Language: English11/10/2026, 9:00 AM
Lotta Borgström Good morning, everyone, and welcome to the Mandatum Q3 2026 audiocast. My name is Lotta Borgström from Investor Relations. Joining me today are our CEO, Petri Niemisvirta, and our CFO,…
Solar foods Go-to-market Update
Language: English11/9/2026, 12:00 PM
Maria Hello everyone, and welcome to the Solar Foods go-to-market update. My name is Maria and I'm here today with our CEO, Rami Jokela, and CFO and Deputy CEO, Ilkka Saura. Also with us today is Heli…
Outokumpu, Webcast, Q3'26
Language: English11/6/2026, 12:30 PM
Johan Welcome to the third quarter results webcast. I am responsible for investor relations. We will start with the presentation from our CEO, Kati ter Horst, and our CFO, Marc-Simon Schaar. After the…
Endomines, Webcast, Q3'26
Language: English11/5/2026, 1:00 PM
Andy Turpin Hello, everyone, and welcome to Endomines' third-quarter results webcast. Thanks for joining us today. My name is Andy Turpin and I am the Chief Communications Officer here at Endomines. A…
Lemonsoft Oyj, Q3'26 webcast
Language: English11/5/2026, 11:00 AM
Unknown 1 Welcome to the Lemonsoft Q3 results presentation. We will start with the presentation from CEO Alpo Luostarinen, followed by the Q&A. You can send your questions throughout the event via the…
Enersense, Webcast, Q3'26
Language: English11/5/2026, 10:30 AM
Liisa Tamminen Hello and welcome to the Enersense Q3 2026 results webcast. My name is Liisa Tamminen from Enersense Investor Relations. And with me here I have our CEO, Kari Sundbäck, and CFO, Jan-Elo…
Sitowise, Q3'26
Language: English11/5/2026, 10:00 AM
Mari Reponen Good day everyone, and welcome to the Sitowise Q3 2026 results audiocast. My name is Mari Reponen, and I am responsible for strategy and IR here at Sitowise. And today with me are our act…
Orthex, Webcast, Q3'26
Language: English11/5/2026, 9:00 AM
Alexander Rosenlew Good morning and welcome to the Orthex Interim Report. My name is Alexander Rosenlew and with me I have Saara Mäkelä, CFO, and Hanna Kukkonen, our CMSO. We will take you through the…
Suominen Oyj, Q3'26
Language: English11/5/2026, 8:30 AM
Anni Luoma Good morning, everyone, and welcome to the Suominen Q3 webcast. My name is Anni Luoma. I am the Manager of External Communications and Investor Relations at Suominen. Here with me are our P…
Lumo, Webcast, Q3'26
Language: English11/5/2026, 8:00 AM
Niina Saarto Good morning, all. Welcome. This is Lumo Homes plc's third quarter result webcast. I am Niina Saarto from Treasury and Investor Relations. Today I have two gentlemen here with me, namely…
CapMan, Webcast, Q3'26
Language: English11/5/2026, 7:30 AM
Charlotte Good morning and welcome to this presentation of CapMan. Q3 2026 interim report. Presenting today we have Pia Kåll, CEO of CapMan. And after the presentation, we will have a Q&A session. You…
Marimekko, Webcast, Q3'26
Language: English11/4/2026, 12:00 PM
Anna Good afternoon. My name is Anna and I am the IRO of Marimekko. It is my pleasure to welcome you to our Q3 webcast. With me, I have our president and CEO, Tiina Alahuhta, who will walk you through…
Administer, Webcast, Q3'26
Language: Finnish11/4/2026, 9:00 AM
Kimmo Herranen Welcome to the Administer Q3 2026 interim report. Results. Meillä on se alkaa. I am Kimmo Herranen. Kalle Lehtonen. Also. Kaarina og. Yelken. Kalle Lehtonen En el coco. Madan. Parannus.…
Kempower, Webcast, Q3'26
Language: English11/4/2026, 8:30 AM
Unknown 1 Powering the planet. Kempower. We charge our planet for the better. By powering the electric movement. We enable quick and scalable EV charging solutions for everyone and everywhere. We ma…